UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 20, 2000
Shire Pharmaceuticals Group plc
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
England and Wales
--------------------------------------------------------------------------------
(State or other jurisdiction of incorporation)
0-29630 N/A
------------------------------------ -----------------------
(Commission File Number) (IRS Employer Identification No.)
East Anton, Andover, Hampshire SP10 5RG England
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code 44-1264-333455
----------------------------
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On August 31, 2000, Shire Pharmaceuticals Group plc ("Shire") entered into
an agreement (the "Termination Agreement") with the former shareholders of Shire
Richwood Inc. ("SRI"), pursuant to which 1,622,566 ordinary shares placed into
escrow at the time of the purchase of SRI by Shire were released and the escrow
agreement and the escrow fund were terminated. Under the terms of the
Termination Agreement, 406,064 of the shares held in the escrow fund were sold
by Societe General as agent of the escrow agent and the net proceeds were
distributed to Shire. Shire received approximately $7 million from the sale of
these shares. The remaining 1,216,502 shares were distributed to the former SRI
shareholders.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: September 20, 2000 SHIRE PHARMACEUTICALS GROUP PLC
By: /s/ Angus Russell
--------------------------------
-2-
